Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
G-SARTAN HCT, TELMISARTAN HCTZ JL, TELMISARTAN HCTZ GXP, ATX TELMISARTAN HCT, TELMISARTAN HCTZ RY, TELMISARTAN HCTZ GPPL (Generic Partners Pty Ltd)
Product name
G-SARTAN HCT, TELMISARTAN HCTZ JL, TELMISARTAN HCTZ GXP, ATX TELMISARTAN HCT, TELMISARTAN HCTZ RY, TELMISARTAN HCTZ GPPL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
187 working days (255)
Active ingredients
telmisartan; hydrochlorothiazide
Registration type
New generic medicine
Indication
Telmisartan and hydrochlorothiazide (tablets) are indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.